Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05765201 · ClinicalTrials.gov registry record
Phacoemulsification at High IOP and Physiologic IOP: Impact on Anterior and Posterior Segment Physiology
A clinical trial, sponsored by Matthew Rauen.
- Completed
- Registry status
- 27
- Enrollment target
NCT05765201: Completed study, sponsored by Matthew Rauen.
NCT05765201 is a clinical trial that has completed, run by Matthew Rauen. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05765201 has completed, sponsored by Matthew Rauen.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the anterior and posterior structure and functional changes and vascular alterations when performing phacoemulsification at high IOP vs low, more physiological IOP using Centurion® Vision System with Active Sentry® handpiece. These devices are approved by the US Food and Drug Administration (FDA).
Primary Outcome
Measurement of fluid usage (ml).
Interventions
- OTHER High IOP
- OTHER Low IOP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2022-09-22 |
| Est. Completion | 2023-05-04 |
What the finished NCT05765201 record still lists
NCT05765201 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 27 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which High IOP is the first listed.
NCT05765201 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05765201 about?
NCT05765201 is a clinical study titled "Phacoemulsification at High IOP and Physiologic IOP: Impact on Anterior and Posterior Segment Physiology". The purpose of this study is to investigate the anterior and posterior structure and functional changes and vascular alterations when performing phacoemulsification at high IOP vs low, more physiological IOP using Centurion® Vision System with Active Sentry® handpiece. These devices are approved by ...
What is the current status of trial NCT05765201?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2022-09-22. Estimated completion is 2023-05-04.
What interventions are being tested in trial NCT05765201?
The interventions under investigation include: High IOP (OTHER), Low IOP (OTHER).
Who is sponsoring clinical trial NCT05765201?
This trial is sponsored by Matthew Rauen, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI